(Statin Consensus Conference)
News conference on Expert Consensus on SLCO1B1 and ApoE Gene Polymorphism Detection and Clinical Application of Statin Drugs (hereinafter referred to as the “Consensus”) was successfully held on Jun15, 2023. It was held during the 10th National Academic Conference on Integrated Traditional Chinese and Western Medicine Laboratory Medicine.
This expert Consensus is the first domestic consensus on genetic testing of statins. The Consensus mentions that it is recommended to test the polymorphisms of SLCO1B1 and APOE genes before taking stains. It will help to realize the precision medicine of statins, improve the effect of lipid-regulating therapy, and reduce or avoid the occurrence of adverse drug reactions.
The conference was hosted by Mr. Tao Zhihua, Director of the Department of Laboratory Medicine of the Second Affiliated Hospital of Zhejiang University School of Medicine, Mr. Yang Ximing, Director of the Department of Laboratory Medicine of Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine and Chairman of the Laboratory Medicine Committee of the Chinese Society of Integrative Medicine, Mr. Gan Ling, Director of the Editorial Department of the Chinese Journal of Laboratory Medicine, and Mr. Liu Xiaogang, General Manager of Wuhan YZY Medical Science and Technology Co., Ltd. , etc., who delivered speeches, and Mr. Tao Zhihua, Director of the Consensus. Mr. Tao Zhihua, Director of the Consensus, interpreted the Consensus, and experts and guests of the Consensus Writing Group participated in the conference and opened the release ceremony together.
(Director Tao Zhihua)
Launching Ceremony: Live Address and Consensus Interpretation Speech
On behalf of Yang Ximing, Chairman of the Professional Committee of Laboratory Medicine of the Chinese Society of Integrative Medicine (CSIM) and Director of the Department of Laboratory Medicine, Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine (BUTM), he expressed his gratitude to the Chinese Society of Integrative Medicine (CSIM) for the support of the Chinese Journal of Laboratory Medicine (CJLM), and to the experts of the Preparation Committee for their hard work, and for the presence of the experts at the meeting.
(Director Yang Ximing)
Director Gan Ling of the Editorial Office of the Chinese Journal of Laboratory Medicine delivered an enthusiastic speech, in which Director Gan Ling highly affirmed the work of the writing committee. Director Gan said that the Consensus is comprehensive and detailed, and is a guiding consensus of great significance for clinical guidance on statin medication.
(Director, Gan ling)
Mr Liu Xiaogang, General Manager of Wuhan YZY Medical Science and Technology Co., Ltd. , delivered a speech at the conference, welcoming the presence of experts. It is believed that the release of the Consensus can greatly improve the relevance of treatment, reduce adverse reactions, avoid ineffective treatment and reduce the economic burden of patients, reduce the waste of medical resources, and thus promote the rational use of medical resources.
(General Manager Liu Xiaogang)
Consensus Interpretation
Tao Zhihua, Director of the Department of Laboratory Medicine of the Second Affiliated Hospital of Zhejiang University School of Medicine, gave a detailed interpretation of the content of the Consensus.
(Director Tao Zhihua)
With the rapid development of contemporary pharmacogenomics, how to improve patients’ healthy life index and therapeutic effect, reduce the occurrence of morbidity and toxic side effects of drugs, and improve patients’ living conditions and quality of life has become a hot spot and a difficult point of common concern for the whole society and the clinical community. Participating experts believe that the Consensus adheres to a problem-oriented approach, meets the needs of clinical work, and assists the clinic in solving the pain points and difficulties of statins.
Case Sharing
Mr. Wen Lang, Marketing Manager of Wuhan YZY Medical Science and Technology Co., Ltd. shared a clinical case of statins genetic testing.
(Lang Wen Manager)
Conference Summary
Finally, Director Tao Zhihua, as the initiator of the consensus, summarized the consensus conference: thanks to Wang Jian’an, Secretary of the Second Affiliated Hospital of Zhejiang University School of Medicine, for his strong support; thanks to all the experts who participated in the consensus writing process of the various discussions and put forward valuable opinions; thanks to the editorial department of the Chinese Journal of Laboratory Medicine, Director Gan Ling, for his help in copy editing, so that we can understand more about the gene-guided The consensus will be published in the Chinese Journal of Laboratory Medicine. The Consensus will be published in the Chinese Journal of Laboratory Medicine, and we hope that more patients will benefit from the publication of the Consensus.
